3SOF

I think we are setup for a big Monday and week. 

its been on the buyins list for 28 days...naked short selling...be careful....

 Forensics Technology Assists Police in Identifying Suspect in California Double Murder
Oct 3, 2005 7:00:00 AM
2005 PrimeZone Media Network
SARASOTA, Fla., Oct. 3, 2005 (PRIMEZONE) -- DNAPrint genomics, Inc. (OTCBB:DNAG) today confirmed that its DNAWITNESS forensics technology narrowed down a list of potential suspects during a police investigation that led to an arrest in the murder of two women in Napa, Calif.

The brutal stabbings of Leslie Ann Mazzara and Adriane Michelle Insogna, both 26, in a home they shared in the Northern California community, had stumped police for nearly 11 months because the women had no known enemies and there was no apparent motive. Police had speculated that the killer knew one or both of the victims.

Being held in custody was a man identified by authorities as Eric Matthew Copple, 26, of Napa. Police conducted more than 1,300 interviews during the investigation and collected DNA samples from 218 individuals, all men who had social or work contact with all three roommates who lived in the home. A third woman escaped unharmed during the Nov. 1, 2004, attack and called police.

The California Department of Justice Crime Lab and DNAPrint genomics previously determined that an analysis of blood samples collected at the crime scene indicated that the suspect was a male. Forensic evidence also pointed to a killer who smoked Camel Turkish Gold cigarettes, a hybrid of the popular cigarette brand. NapaPolice issued a statement to the media on Sept. 22, 2005, saying that DNAPrint genomics' forensics laboratory had further determined that the ancestry of the person of interest was white with 96% Northern European ancestry and 4% Southeastern European.

"We received a DNA sample from the Napa Police on Nov. 23, 2004 and returned the results of our DNAWITNESS analysis two days later," stated DNAPrint genomics President and Chief Executive Officer Richard Gabriel. "More recently, the case was revisited when DNAPrint was asked to analyze the sample with our EUROWitness technology to further refine the information. With information from DNAPrint, the Napa Police Department did a media release describing a white male adult who smokes or did smoke Camel Turkish Brand Cigarettes."

The San Francisco Chronicle newspaper reported that Napa Police Department Investigations Bureau Commander Jeff Troendy confirmed that DNA-related evidence and the media release led to the arrest of Copple. Troendy was quoted as saying, "The media release last week helped us get to this point, sometimes things happen very quickly."

About DNAPrint genomics, Inc.

Today's activity looks bullish, but then again, this stock has had many, many false rallies.

One thing which is promising is that the PR blitz is likely to continue.

Volume 8.5MM

Good luck,

poorman1

Here's the updated DNAG chart at the end of Monday, Oct. 3, 2005.

I'm not sure if this indicates a gap-down tomorrow or what tomorrow.

Good luck,

poorman1

Im liking the chart, I think we could see an explosion in the stock price.  I like the improving RSI and the vokume today!  This is an early indication of a big pps increase.  Now I think this is a good indication that we will have a good PR coming also.  Remember MM's control the price and I believe that they will be selling at a much higher pps.

DNAPrint genomics Receives Notice of Allowance for Patent for Processing Gene Sequence Data
10/27/2005 07:00
SARASOTA, Fla., Oct. 27, 2005 (PRIMEZONE) -- DNAPrint genomics, Inc. (OTCBB: DNAG), a developer of genomics-based products and services, today announced that it has been granted a notice of allowance from the U.S. Patent and Trademark Office for its patent application for Efficient Methods and Apparatus for High-Throughput Processing of Gene Sequence Data.

"Though we are all 99.9% identical at the level of our DNA, it is the 0.1% difference called polymorphism that accounts for our individuality," stated Tony N. Frudakis, Ph.D., DNAPrint's founder and Chief Scientific Officer. "The technology our patent application covers relates to methods useful for measuring polymorphisms in and around genes that are part of large gene families, a task that traditionally has been problematic for the molecular genetics community."

Geneticists use "molecular addresses" to query and study specific genes much like a postman uses a street address to find the recipient of a letter. The methods covered in the patent are useful when there are several genes with the same or substantially similar "sequence" addresses. Many of the genes that are involved in drug metabolism and response are members of large gene families.

This is the first patent for which the Company applied. The methods covered in the application, first drafted in 2001, were originally developed to power DNAPrint's unique approach to pharmacogenomics research, which is aimed at understanding why people respond uniquely to drugs.

About DNAPrint genomics, Inc.

DNAPrint genomics, Inc. (www.dnaprint.com) is a developer of genomics-based products and services focused on drug development, pharmacogenomic diagnostic tests, forensics technology and consumer genetic tests. The Company's first theranostic product (drug/test combination) is PT-401, a "Super EPO" (erythropoietin) dimer protein drug for treatment of anemia in renal dialysis patients (end stage renal disease). Currently in pre-clinical development, PT-401 will be targeted to patients with a genetic profile indicating their propensity to have the best clinical response. DNAPrint's family of products for the law enforcement forensics and consumer markets include DNAWITNESS, RETINOME, ANCESTRYbyDNA and EURO-DNA.

Forward Looking Statements

All statements in this press release that are not historical are forward-looking statements. Such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including, but not limited to, uncertainties relating to technologies, product development, manufacturing, market acceptance, cost and pricing of DNAPrint's products, dependence on collaborations and partners, regulatory approvals, competition, intellectual property of others, and patent protection and litigation. DNAPrint genomics, Inc. expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in DNAPrint's expectations with regard thereto or any change in events, conditions, or circumstances on which any such statements are based.
CONTACT:  DNAPrint genomics, Inc.
          Richard Gabriel, President and CEO
          (941) 366-3400
         
          The Wall Street Group, Inc.
          Ron Stabiner
          (212) 888-4848

This one is so hated by investors and so loved by shortsellers naked or not. So much that the stock looks like a steal at current PPS.

Market cap now is only 894.53K @.0141

Price/Sales (ttm):   1.00   
Price/Book (mrq):   0.94

last PR about patent should increase book value some too.

What´s interesting is:
number of shares outstanding has stayed at 63.44M since July 12. This could be a sign that DNAGs burnrate is low now or even better they are cash flow positive? That would mean the dilution death spiral has stopped.

The reaction from the market to the news releases haven't been that strong. Anyway, the news has had more financial significance for every release.

Will be very interesting to see how market takes this latest piece of news. 

Hello.....may be ready to make a run north.

Maybe it is about time.

No news and up 10% on good volume.  Momentum is definitely picking up.

poorman1

Hello.....on the move !
+17.83%......Volume @........2,686,571.......Let's rock !

The company DNAG is going to acquire appears to be legitamite.  The executives seam to be well established in their fields.  Here's the companies website:

http://www.kennatechnologies.com/about.html

Here's the 5-day chart on DNAG.  The spike this morning did not result in a huge selloff.  Looks as if it could go much higher as accumulation occurred in the afternoon.

poorman1

Stock of the day...

Buy DNAG without no doubt...Great news and great chart
News : cf. previous topics

Technicals :
Gap
High volume
Good support with volume accumulation